Acasti pharma inc. announces the resignation of a director

Laval, qc , march 30, 2023 /prnewswire/ -- acasti pharma inc. ("acasti" or the "company") (nasdaq: acst) a late-stage, specialty pharma company advancing three clinical stage drug candidates addressing rare and orphan diseases, today announced that mr. jean-marie (john) canan had tendered his resignation from the board of directors of the company, such resignation to take effect immediately.
ACST Ratings Summary
ACST Quant Ranking